BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1055 related articles for article (PubMed ID: 33555484)

  • 1. Paraneoplastic cerebellar degeneration as a presenting manifestation of non-Hodgkin's lymphoma.
    Nanda S; Handa R; Prasad A; Anand R; Zutshi D; Dass SK; Bedi PK; Pahuja A; Shah PK; Sharma B; Malhotra N
    Neurol Sci; 2021 Jun; 42(6):2523-2525. PubMed ID: 33555484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian mass Presenting as Paraneoplastic cerebellar degeneration with peripheral neuropathy and anti-Yo antibody.
    Sahoo D; Dey A; Dash A; Dash A
    BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38272525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraneoplastic cerebellar and brainstem disorders.
    Abbatemarco JR; Vedeler CA; Greenlee JE
    Handb Clin Neurol; 2024; 200():173-191. PubMed ID: 38494276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hodgkin's lymphoma presenting as a complex paraneoplastic neurological syndrome: a case report.
    Ammannagari N; Chikoti S; Bravin E
    J Med Case Rep; 2013 Apr; 7():96. PubMed ID: 23566362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraneoplastic Cerebellar Degeneration Revealing Non-Small Cell Lung Cancer: A Case Report.
    Kharouaa B; Boukhidous L; Hayoune A; Gartini S; Charii H; Rhazari M; Thouil A; Kouismi H
    Cureus; 2024 May; 16(5):e60258. PubMed ID: 38872688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective study of autoimmune cerebellar ataxia over a 20-year period in a single institution.
    Kudo A; Yaguchi H; Tanaka K; Kimura A; Yabe I
    J Neurol; 2024 Jan; 271(1):553-563. PubMed ID: 37610447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhombencephalomyelitis due to possible paraneoplastic syndrome associated with Hodgkin's lymphoma.
    Valappil A; Radhakrishnan Nair R; Madhusoodhanan S; Narendran A
    BMJ Case Rep; 2022 Apr; 15(4):. PubMed ID: 35450877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraneoplastic syndromes associated with classic Hodgkin lymphoma, a systematic literature review.
    El Fakih R; Bajuaifer YS; Shah AY; Sulaiman R; Almohamady R; ELGohary G; Alothaimeen HS; Aljurf M
    Ann Hematol; 2024 Apr; 103(4):1131-1137. PubMed ID: 37428199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraneoplastic movement disorders.
    McKeon A; Tracy J
    Handb Clin Neurol; 2024; 200():211-227. PubMed ID: 38494279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraneoplastic Syndrome Case Presented As Nystagmus and Ataxia.
    Darwesh KM
    Cureus; 2024 Feb; 16(2):e55153. PubMed ID: 38558653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hodgkin's Lymphoma in a Man with Dilated Cardiomyopathy and Paraneoplastic Ataxia: A Therapeutical Challenge.
    Abruzzese E; Trawinska MM; Gaspardone A; Morocutti A; de Fabritiis P
    Hematol Rep; 2017 Jun; 9(2):6944. PubMed ID: 28702159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follicular lymphoma associated paraneoplastic myositis.
    Melody M; Parrondo R; Alhaj Moustafa M; Wu K; Menke D; Seim L; Tun HW
    Clin Case Rep; 2020 Oct; 8(10):2003-2006. PubMed ID: 33088539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary pulmonary Hodgkin's lymphoma with pulmonary histoplasmosis.
    Chowdhary GS; Mehta R; Tyagi R
    Med J Armed Forces India; 2020 Oct; 76(4):462-465. PubMed ID: 33162658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gynecologic clear cell carcinoma and paraneoplastic cerebellar Degeneration: A literature review and case study.
    Tierney M; Landenwich E; Piecoro D; Liau J; Burke E; Dietrich CS; Hutchcraft ML
    Gynecol Oncol Rep; 2024 Apr; 52():101365. PubMed ID: 38500640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commentary: Paraneoplastic Syndrome Associated with Kelch-Like Protein 11 Antibodies Presenting with Progressive Ataxia and Tremor.
    Fasano A; Prakash P; Bledsoe IO; Balint B
    Mov Disord Clin Pract; 2021 Aug; 8(Suppl 1):S45-S46. PubMed ID: 34514049
    [No Abstract]   [Full Text] [Related]  

  • 16. Peripheral Nervous System Manifestations Associated with COVID-19.
    Andalib S; Biller J; Di Napoli M; Moghimi N; McCullough LD; Rubinos CA; O'Hana Nobleza C; Azarpazhooh MR; Catanese L; Elicer I; Jafari M; Liberati F; Camejo C; Torbey M; Divani AA
    Curr Neurol Neurosci Rep; 2021 Feb; 21(3):9. PubMed ID: 33586020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients.
    Cornberg M; Buti M; Eberhardt CS; Grossi PA; Shouval D
    J Hepatol; 2021 Apr; 74(4):944-951. PubMed ID: 33563499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 mRNA vaccines (Pfizer-BioNTech and Moderna) in patients with multiple sclerosis: a statement by a working group convened by the Section of Multiple Sclerosis and Neuroimmunology of the Polish Neurological Society.
    Nojszewska M; Kalinowska A; Adamczyk-Sowa M; KuĊ‚akowska A; Bartosik-Psujek H
    Neurol Neurochir Pol; 2021; 55(1):8-11. PubMed ID: 33555604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of SARS-CoV-2 Brain Invasion and Histopathology in COVID-19 Disease.
    Serrano GE; Walker JE; Arce R; Glass MJ; Vargas D; Sue LI; Intorcia AJ; Nelson CM; Oliver J; Papa J; Russell A; Suszczewicz KE; Borja CI; Belden C; Goldfarb D; Shprecher D; Atri A; Adler CH; Shill HA; Driver-Dunckley E; Mehta SH; Readhead B; Huentelman MJ; Peters JL; Alevritis E; Bimi C; Mizgerd JP; Reiman EM; Montine TJ; Desforges M; Zehnder JL; Sahoo MK; Zhang H; Solis D; Pinsky BA; Deture M; Dickson DW; Beach TG
    medRxiv; 2021 Feb; ():. PubMed ID: 33619496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. Reply.
    Absalon J; Koury K; Gruber WC
    N Engl J Med; 2021 Apr; 384(16):1578. PubMed ID: 33596351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 53.